Up To 50 SAR OFF Your First Order Use Code : APP50 | Get Free Delivery With No Minimum Order

Frequently bought together
TOPFEROL 50000 IU 8 TAB
- Sku : I-033677
Key features
TOPFEROL 50000 IU 8 TAB is a film-coated tablet supplement delivering Cholecalciferol (Vitamin D3) 50,000 IU per tablet. It corrects and helps prevent vitamin D deficiency while supporting bone health, calcium absorption and immune function, suitable for individuals with low vitamin D levels or increased supplementation needs. Formulated with cholecalciferol-the most bioavailable form of vitamin D and approximately 87% more effective than ergocalciferol (D2) at raising and sustaining serum 25‑hydroxyvitamin D-TOPFEROL offers reliable potency and stability. Serving size is one film-coated tablet; pack contains 8 tablets.- Brand: TOPFEROL
- Supplement Type: Vitamin
- Active Compounds: Cholecalciferol (Vitamin D3) 50,000 IU
- Supplement Form: Film-coated tablet
- Serving Size: 1 film-coated tablet
- Servings Per Container: 8
- Pack Size: 8 Tablets
- Primary Benefit: Corrects and prevents vitamin D deficiency, supporting bone health, calcium absorption, and immune function
- Bioavailability Form: Cholecalciferol (Vitamin D3) - the most bioavailable form of vitamin D, approximately 87% more effective than ergocalciferol (D2) at raising and sustaining serum 25-hydroxyvitamin D levels
- Prescription Status: Prescription
- Certification: SFDA registered (Registration No. 2001268967); GMP manufactured by Pharma International Co., Jordan
- Manufacturer: Pharma International Co.
- Country of Origin: Jordan
- SFDA Registration No.: 2001268967
- Shelf Life: 24 months
- Vitamin D Form: D3
- Calcium Included: No
- Vitamin K Included: No
Frequently bought together
Benefits & Uses
Primary Benefit
Corrects and prevents vitamin D deficiency, supporting bone health, calcium absorption, and immune function
Health Claims
Correction of vitamin D deficiency and insufficiency; supports normal bone mineralization and maintenance; contributes to normal muscle function; supports immune system function; aids intestinal calcium and phosphorus absorption
Common Deficiency Symptoms
Fatigue, bone pain, muscle weakness, frequent infections, depression, hair loss, impaired wound healing, rickets in children, osteomalacia in adults
Target Population
Adults diagnosed with vitamin D deficiency or insufficiency; individuals with limited sun exposure; elderly patients; patients with malabsorption syndromes; individuals with obesity; patients on medications that impair vitamin D metabolism
Scientific Evidence Level
Strong
Onset Timeline
Serum 25(OH)D levels begin rising within 1-2 weeks of weekly dosing; deficiency correction typically achieved within 8-12 weeks of therapeutic dosing; bone density improvements require 3-6 months of sustained adequate levels
Usage & Dosage
Suggested Use
Take 1 tablet as directed by a physician, typically once weekly or as prescribed, with a fat-containing meal
Serving Size
1 film-coated tablet
Servings Per Container
8
Best Time to Take
With meals (preferably with the largest fat-containing meal of the day)
Recommended Daily Intake
Adults: 600-800 IU/day (15-20 mcg); therapeutic doses of 50,000 IU are prescribed weekly or as directed by a physician for deficiency correction
Upper Tolerable Limit
4,000 IU/day (100 mcg) for adults as a general population UL; therapeutic doses above this level require medical supervision and monitoring of serum calcium and 25(OH)D
Absorption Enhancers
Dietary fat (increases micellar solubilization and lymphatic absorption); magnesium (cofactor for vitamin D metabolism); bile acids
Absorption Inhibitors
Orlistat (blocks fat absorption, significantly reduces vitamin D absorption); cholestyramine and colestipol (bile acid sequestrants impair absorption); mineral oil; high-dose calcium supplements taken simultaneously
Side Effects
Possible Side Effects
At prescribed therapeutic doses: generally well-tolerated. Excessive or prolonged high-dose use may cause hypercalcemia, hypercalciuria, nausea, vomiting, constipation, polyuria, polydipsia, weakness, confusion, and nephrocalcinosis
Toxicity Risk
Medium
Upper Tolerable Limit
4,000 IU/day (100 mcg) for adults as a general population UL; therapeutic doses above this level require medical supervision and monitoring of serum calcium and 25(OH)D
Safety & Warnings
Contraindications
Known hypersensitivity to cholecalciferol/excipients; hypercalcemia and/or hypercalciuria; hypervitaminosis D; conditions predisposing to hypercalcemia (e.g., primary hyperparathyroidism, granulomatous diseases such as sarcoidosis); severe renal impairment/renal failure; nephrolithiasis (calcium stones) or severe nephrocalcinosis.
Pregnancy Safety
Consult Doctor
Breastfeeding Safety
Consult Doctor
Children Suitability
Not recommended under 18 unless prescribed by a physician.
Interactions
Medication Interactions
Orlistat reduces absorption; thiazide diuretics increase risk of hypercalcemia when combined with high-dose vitamin D; corticosteroids impair vitamin D metabolism; anticonvulsants (phenytoin, phenobarbital) accelerate vitamin D catabolism; rifampicin reduces vitamin D efficacy
Supplement Interactions
High-dose calcium supplements taken concurrently increase hypercalcemia risk; magnesium deficiency impairs conversion to active form; iron absorption is not directly affected
Synergistic Nutrients
Vitamin K2 (MK-7) directs calcium to bones and away from arteries; magnesium (essential cofactor for vitamin D hydroxylation); calcium (vitamin D enhances intestinal calcium absorption); zinc (supports vitamin D receptor function)
Special Populations
Target Population
Adults diagnosed with vitamin D deficiency or insufficiency; individuals with limited sun exposure; elderly patients; patients with malabsorption syndromes; individuals with obesity; patients on medications that impair vitamin D metabolism
Children Suitability
Not recommended under 18 unless prescribed by a physician.
Pregnancy Safety
Consult Doctor
Breastfeeding Safety
Consult Doctor
Storage & Patient Advice
SFDA Storage Conditions
store below 30°c
Storage Conditions
Store below 30°C.
Patient Counseling
Oral cholecalciferol 50,000 IU film‑coated tablet: take exactly as prescribed (commonly once weekly for deficiency, but follow the prescriber’s schedule-do not take daily unless specifically instructed). Take with/after a meal (preferably containing fat) to improve absorption. Do not exceed the dose or add other vitamin D/calcium supplements unless approved. Monitoring of serum 25‑OH vitamin D and calcium (± phosphate/creatinine) is recommended during high‑dose therapy. Seek medical advice urgently if symptoms of hypercalcemia/vitamin D toxicity occur (e.g., nausea/vomiting, constipation, excessive thirst/polyuria, weakness, confusion).
Science & Evidence
Bioavailability Form
Cholecalciferol (Vitamin D3) - the most bioavailable form of vitamin D, approximately 87% more effective than ergocalciferol (D2) at raising and sustaining serum 25-hydroxyvitamin D levels
Water or Fat Soluble
Fat-soluble
Scientific Evidence Level
Strong
Onset Timeline
Serum 25(OH)D levels begin rising within 1-2 weeks of weekly dosing; deficiency correction typically achieved within 8-12 weeks of therapeutic dosing; bone density improvements require 3-6 months of sustained adequate levels
Food Sources
Fatty fish (salmon, mackerel, sardines, tuna), cod liver oil, egg yolks, beef liver, UV-exposed mushrooms, fortified milk and dairy products, fortified cereals
Product Information
Supplement Type
Vitamin
Certification
SFDA registered (Registration No. 2001268967); GMP manufactured by Pharma International Co., Jordan
Suitable for Vegetarians
Yes
Suitable for Vegans
No
Vitamin D Form
D3
Calcium Included
No
Vitamin K Included
No
-1744229570.gif)





